Integral Health Asset Management, LLC

CIK 0001773206 · NEW YORK, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Integral Health Asset Management, LLC reported 92 positions worth $2.53B as of June 30, 2026 (13F filed August 14, 2026). Largest holding: RVMD (11.1%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$2.53B
2026 Q2
Positions
92
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
44.8%
Est. Net Flow (Q)
2026 Q2
10 / 92 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1RVMDREVOLUTION MEDICINES INCSH$280.9M11.10%1,500,000
2INSMINSMED INCSH$170.6M6.74%1,600,000
3CYTKCYTOKINETICS INCSH$136.3M5.38%1,600,000
4CVSCVS HEALTH CORPSH$113.8M4.49%1,100,000
5EWTXEDGEWISE THERAPEUTICS INCSH$81.3M3.21%2,000,000
6VERAVERA THERAPEUTICS INCSH$75.1M2.97%1,750,000
7AXSMAXSOME THERAPEUTICS INC.SH$73.4M2.90%300,000
8CAHCARDINAL HEALTH INCSH$71.3M2.81%300,000
9ROIVROIVANT SCIENCES LTDSH$70.8M2.80%2,000,000
10RYTMRHYTHM PHARMACEUTICALS INCSH$61.1M2.41%550,000

The free plan shows the top 10 positions. The remaining 82 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Integral Health Asset Management, LLC hold as of Q2 2026?

Integral Health Asset Management, LLC reported 92 positions worth $2.53B in its Q2 2026 13F filing. Largest positions: RVMD (11.1%), INSM (6.7%), CYTK (5.4%), CVS (4.5%) and EWTX (3.2%).

What did Integral Health Asset Management, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Integral Health Asset Management, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.